
|Articles|January 1, 2017
- Pharmaceutical Executive-01-01-2017
- Volume 37
- Issue 1
Pharmaceutical Executive, January 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Path of Uncertainty: Pharm Exec’s 2017 Industry Forecastover 9 years ago
Biopharma Change Agent: Belén Garijoover 9 years ago
The ‘Healthcare Internet of Things’over 9 years ago
Pharma and Biotech Markets: Challenges and Opportunitiesover 9 years ago
Win Your Brand with Actionover 9 years ago
The State of Market Insights in Pharmaover 9 years ago
Country Report: PhilippinesNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
Pharmaceutical Risks in the Strait of Hormuz
5




